Literature DB >> 16870866

Infectious keratoconjunctivitis in bighorn sheep, Silver Bell Mountains, Arizona, USA.

Brian D Jansen1, James R Heffelfinger, Ted H Noon, Paul R Krausman, James C Devos.   

Abstract

An infectious keratoconjunctivitis (IKC) epizootic in bighorn sheep (Ovis canadensis) occurred in the Silver Bell Mountains, Arizona, USA, from 1 December 2003 to 31 March 2004. We used standard culture methods and polymerase chain reaction (PCR) amplification of the 16S rRNA gene to test for the causative agents of IKC and other diseases reported to be associated with bighorn sheep populations. All bighorn sheep and domestic goat test results were negative except for Mycoplasma spp. and Branhamella spp. The culture and PCR results differed. Conjunctival swabs from four of 19 IKC-affected bighorn sheep tested by culture were positive for Mycoplasma spp., whereas 22 of 22 bighorn sheep samples tested by PCR were positive for Mycoplasma spp. None of 13 domestic goats tested positive by culture for Mycoplasma spp., whereas five of 16 tested positive by PCR. Three of 16 domestic goats and seven of 24 IKC-affected bighorn sheep tested positive for Branhamella spp. by culture. Bighorn sheep began showing clinical signs of IKC between 21 and 28 days following initial detection of domestic goats in bighorn sheep habitat. The IKC epizootic lasted 122 days, and individual bighorn sheep were blind for an average of 38.4 days. Given the clear potential for disease transmission to bighorn sheep, we recommend that land managers not allow the pasturing of domestic goats near occupied bighorn sheep habitat.

Entities:  

Mesh:

Year:  2006        PMID: 16870866     DOI: 10.7589/0090-3558-42.2.407

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  7 in total

1.  Prevalence, molecular diagnosis and treatment of Mycoplasma conjunctivae isolated from infectious keratoconjunctivitis affected Lohi sheep maintained at Livestock Experiment Station, Bahadurnagar, Okara, Pakistan.

Authors:  Waseem Shahzad; Rashid Munir; Mohammad Younus Rana; Rashid Ahmad; Mohammad Sarwar Khan; Ghulam Akbar; Mohammad Ijaz; Fayyaz Mehmood
Journal:  Trop Anim Health Prod       Date:  2012-11-08       Impact factor: 1.559

2.  Infectious keratoconjunctivitis in wild Caprinae: merging field observations and molecular analyses sheds light on factors shaping outbreak dynamics.

Authors:  Giuseppina Gelormini; Dominique Gauthier; Edy M Vilei; Jean-Paul Crampe; Joachim Frey; Marie-Pierre Ryser-Degiorgis
Journal:  BMC Vet Res       Date:  2017-03-04       Impact factor: 2.741

3.  Genetic assessment of a bighorn sheep population expansion in the Silver Bell Mountains, Arizona.

Authors:  John A Erwin; Karla Vargas; Brian R Blais; Kendell Bennett; Julia Muldoon; Sarah Findysz; Courtney Christie; James R Heffelfinger; Melanie Culver
Journal:  PeerJ       Date:  2018-11-30       Impact factor: 2.984

4.  Dynamics of an infectious keratoconjunctivitis outbreak by Mycoplasma conjunctivae on Pyrenean Chamois Rupicapra p. pyrenaica.

Authors:  Maríacruz Arnal; Juan Herrero; Christian de la Fe; Miguel Revilla; Carlos Prada; David Martínez-Durán; Angel Gómez-Martín; Olatz Fernández-Arberas; Joaquín Amores; Antonio Contreras; Alicia García-Serrano; Daniel Fernández de Luco
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

5.  A Review of Hypothesized Determinants Associated with Bighorn Sheep (Ovis canadensis) Die-Offs.

Authors:  David S Miller; Eric Hoberg; Glen Weiser; Keith Aune; Mark Atkinson; Cleon Kimberling
Journal:  Vet Med Int       Date:  2012-03-29

6.  Potential disease agents in domestic goats and relevance to bighorn sheep (Ovis canadensis) management.

Authors:  Mark L Drew; Glen C Weiser
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

7.  Long-term dynamics of Mycoplasma conjunctivae at the wildlife-livestock interface in the Pyrenees.

Authors:  Xavier Fernández-Aguilar; Oscar Cabezón; Joachim Frey; Roser Velarde; Emmanuel Serrano; Andreu Colom-Cadena; Giuseppina Gelormini; Ignasi Marco; Gregorio Mentaberre; Santiago Lavín; Jorge Ramón López-Olvera
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.